Metagenomi TherapeuticsMGX
13F holders, Q4 2024 (December 31)77holders +10
21new positions
13sold out
3famous investors
$3.61avg. 13F price*
At the end of Q4 2024, 77 institutions reported holding Metagenomi Therapeutics Inc. (MGX) in their 13F filings, up 10 from Q3 2024. 21 opened new positions and 13 sold out. The largest holders were BlackRock, Inc. ($5.2M), Vanguard Group Inc. ($4.6M) and PFM Health Sciences, LP ($3.2M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Metagenomi Therapeutics Inc.
- CUSIP
- 59102M104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 21 | $2.6M |
| Exits | 13 | $11.0M |
All 13F filers, Q3 2024 → Q4 2024: 4,772,885 shares bought and 6,573,836 shares sold, net −1,800,951 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 77 holders
| BlackRock, Inc. | 0.00% | Add +231.7% | 1,444,948 | $5.2M |
| Vanguard Group Inc. | 0.00% | Add +239.2% | 1,268,389 | $4.6M |
| PFM Health Sciences, LP | 0.25% | Reduce -14.3% | 885,803 | $3.2M |
| HHLR Advisors, LTD. | 0.10% | No change | 777,768 | $2.8M |
| Morgan Stanley | 0.00% | Add +1100.2% | 775,786 | $2.8M |
| Geode Capital Management, LLC | 0.00% | Add +73.8% | 587,421 | $2.1M |
| Sozo Ventures GP II, L.P. | 100.00% | No change | 581,577 | $2.1M |
| Catalio Capital Management, LP | 0.42% | — | 528,993 | $1.9M |
| State Street Corp. | 0.00% | Add +1298.3% | 429,904 | $1.6M |
| Norges Bank | 0.00% | No change | 360,202 | $1.3M |
| Peapod Lane Capital LLC | 1.26% | — | 351,213 | $1.3M |
| Pura Vida Investments, LLC | 5.28% | Reduce -2.3% | 264,391 | $954K |
| Northern Trust Corp. | 0.00% | Add +185.6% | 223,934 | $808K |
| Goldman Sachs Group Inc. | 0.00% | Add +782.3% | 173,184 | $625K |
| Renaissance Technologies | 0.00% | Reduce -15.5% | 153,800 | $555K |
| Citadel Advisors | 0.00% | Reduce -81.4% | 149,698 | $540K |
| Good Life Advisors, LLC | 0.03% | New | 125,000 | $451K |
| Acadian Asset Management LLC | 0.00% | Add +3075.6% | 117,338 | $422K |
| Wells Fargo & Company | 0.00% | Add +54.5% | 95,188 | $344K |
| Bridgeway Capital Management, LLC | 0.01% | No change | 92,200 | $333K |
| Resolute Advisors LLC | 0.07% | Add +239.4% | 89,944 | $325K |
| Fortitude Advisory Group L.L.C. | 0.16% | New | 75,740 | $273K |
| Spire Wealth Management | 0.01% | New | 73,844 | $267K |
| JPMorgan Chase & Co. | 0.00% | Add +811.6% | 73,031 | $264K |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -51.6% | 66,182 | $239K |
| Charles Schwab Investment Management Inc. | 0.00% | Add +344.9% | 65,753 | $237K |
| Nuveen Asset Management, LLC | 0.00% | New | 63,248 | $228K |
| BBR Partners, LLC | 0.01% | New | 53,403 | $193K |
| Verition Fund Management LLC | 0.00% | Add +40.2% | 52,835 | $191K |
| Marquette Asset Management, LLC | 0.03% | New | 51,080 | $184K |
| Marshall Wace, LLP | 0.00% | Reduce -71.6% | 47,922 | $173K |
| Barclays PLC | 0.00% | Add +388.4% | 42,481 | $153K |
| Diametric Capital, LP | 0.10% | New | 41,615 | $150K |
| UBS Group AG | 0.00% | Add +331.0% | 39,050 | $141K |
| Bank of New York Mellon Corp | 0.00% | New | 36,091 | $130K |
| Prelude Capital Management, LLC | 0.01% | Add +156.1% | 36,042 | $130K |
| Jane Street Group, LLC | 0.00% | New | 29,758 | $107K |
| Sei Investments Co. | 0.00% | New | 27,751 | $100K |
| Focus Partners Wealth | 0.00% | New | 27,381 | $99K |
| Two Sigma Investments, LP | 0.00% | Reduce -69.1% | 26,471 | $96K |
| Pinnacle Wealth Planning Services, Inc. | 0.01% | New | 25,439 | $92K |
| Brown Advisory Inc. | 0.00% | No change | 25,006 | $90K |
| Green Alpha Advisors, LLC | 0.07% | Reduce -23.6% | 24,230 | $87K |
| Citigroup Inc. | 0.00% | Add +372.6% | 21,586 | $78K |
| Bank of America Corp. | 0.00% | Add +482.9% | 21,113 | $76K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +338.7% | 15,193 | $55K |
| Marex Group Ltd | 0.00% | New | 15,000 | $54K |
| Millennium Management | 0.00% | Reduce -96.5% | 14,409 | $52K |
| New York State Common Retirement Fund | 0.00% | No change | 13,900 | $50K |
| Prudential Financial Inc. | 0.00% | Reduce -37.0% | 13,725 | $50K |
| Pathstone Holdings, LLC | 0.00% | Reduce -33.9% | 13,648 | $49K |
| Corebridge Financial, Inc. | 0.00% | Add +303.1% | 13,602 | $49K |
| Bank of Montreal | 0.00% | Add +8.0% | 13,441 | $49K |
| Rhumbline Advisers | 0.00% | Add +123.3% | 11,998 | $43K |
| SG Americas Securities, LLC | 0.00% | New | 12,010 | $43K |
| Susquehanna International Group, LLP | 0.00% | New | 11,812 | $43K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 11,577 | $42K |
| T. Rowe Price Associates Inc. | 0.00% | New | 10,755 | $39K |
| Voya Investment Management LLC | 0.00% | New | 10,314 | $37K |
| FMR LLC | 0.00% | Add +91.0% | 8,633 | $31K |
| US Bancorp \de | 0.00% | No change | 4,500 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -26.2% | 3,872 | $14K |
| Legal & General Group Plc | 0.00% | Add +450.1% | 2,701 | $10K |
| BNP Paribas Financial Markets | 0.00% | Reduce -80.4% | 2,504 | $9K |
| California State Teachers Retirement System | 0.00% | Add +350.8% | 2,060 | $7K |
| IFP Advisors, Inc | 0.00% | New | 2,000 | $7K |
| Russell Investments Group, Ltd. | 0.00% | New | 1,892 | $7K |
| Royal Bank of Canada | 0.00% | Add +84.5% | 1,697 | $6K |
| Cwm, LLC | 0.00% | Add +1819.3% | 1,689 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,469 | $5K |
| Principal Securities, Inc. | 0.00% | Add +109.2% | 1,437 | $5K |
| Deutsche Bank AG | 0.00% | New | 1,033 | $4K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 618 | $2K |
| Nisa Investment Advisors, LLC | 0.00% | Add +6712.5% | 545 | $2K |
| Sterling Capital Management LLC | 0.00% | Add +2766.7% | 344 | $1K |
| Amalgamated Bank | 0.00% | No change | 218 | $1K |
| Larson Financial Group LLC | 0.00% | No change | 50 | $181 |
"% of holder's portfolio" is MGX's weight in each manager's 13F, not the share of Metagenomi Therapeutics Inc. the manager owns.